Data Integrity Concerns, Quality Controls Prompt 483 for Specialty Drugmaker

Drug Industry Daily
A A
Unrestricted access to electronic records and a series of quality control deficiencies resulted in a seven-observation 483 for a specialty drugmaker based in Maryland.

To View This Article:

Login

Subscribe To Drug Industry Daily